data_2hq3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hq3 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 1.584 ' HZ1' ' CE ' ' A' ' 35' ' ' LYS . 58.5 tttt . . . . . 0 C--O 1.212 -0.894 0 N-CA-C 109.975 -0.38 . . . . 2.4700000000000002 109.975 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.542 ' HB1' ' HA ' ' A' ' 52' ' ' VAL . . . -136.85 144.27 43.5 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 118.015 0.37 . . . . 0.40000000000000002 111.231 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 1.188 ' NE2' ' CG ' ' A' ' 37' ' ' GLN . 13.4 pt20 -148.48 135.33 19.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.28 -0.418 . . . . 1.8500000000000001 110.185 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 1.013 HG22 ' CB ' ' A' ' 38' ' ' ILE . 30.9 pt -116.71 135.77 55.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.037 0.446 . . . . 1.1599999999999999 110.997 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 1.57 ' CZ ' ' CD1' ' A' ' 39' ' ' PHE . 40.9 t80 -104.38 122.56 45.72 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.298 -0.63 . . . . 2.4500000000000002 109.298 176.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 1.037 HD21 ' CG ' ' A' ' 40' ' ' LEU . 9.6 mp -91.11 146.51 23.78 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.106 -0.497 . . . . 1.47 111.286 -176.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 1.068 ' OE1' ' CG ' ' A' ' 41' ' ' GLU . 36.6 tt0 -73.71 125.45 28.11 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.719 -0.475 . . . . 1.49 109.719 178.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.38 -27.28 8.72 Favored Glycine 0 C--O 1.184 -3.025 0 C-N-CA 120.713 -0.756 . . . . 1.3300000000000001 111.957 -177.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 13.1 t -92.06 125.87 55.24 Favored Pre-proline 0 C--N 1.285 -2.234 0 O-C-N 121.236 -1.155 . . . . 1.47 110.258 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 4.2 Cg_exo -80.9 0.44 10.02 Favored 'Trans proline' 0 N--CA 1.44 -1.632 0 C-N-CA 123.504 2.802 . . . . 1.47 112.913 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 1.018 ' HB1' ' CA ' ' A' ' 45' ' ' ALA . . . -118.68 134.4 23.53 Favored Pre-proline 0 C--N 1.296 -1.722 0 O-C-N 121.875 -0.516 . . . . 1.5800000000000001 111.709 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -90.58 146.1 4.01 Favored 'Trans proline' 0 N--CA 1.44 -1.642 0 C-N-CA 123.499 2.799 . . . . 0.93999999999999995 112.367 176.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 1.436 HD23 ' CG ' ' A' ' 47' ' ' LEU . 6.9 tt -96.23 113.36 24.95 Favored 'General case' 0 C--N 1.285 -2.216 0 O-C-N 121.507 -0.746 . . . . 1.76 109.021 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 1.419 ' HE2' ' CD1' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -111.81 140.61 46.31 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.675 0.274 . . . . 3.0800000000000001 111.584 -178.178 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 1.634 ' CG ' ' CE2' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -146.41 145.35 30.22 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 116.077 -0.51 . . . . 2.8399999999999999 109.886 177.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 m -63.32 -42.2 98.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.142 0.496 . . . . 1.5 110.782 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 1.068 ' NE2' ' CG ' ' A' ' 51' ' ' GLN . 60.0 mt-30 -76.54 114.41 15.23 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.265 -0.425 . . . . 1.72 110.552 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.542 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . 14.5 t -62.72 -50.6 79.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.138 0.494 . . . . 0.95999999999999996 109.789 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.588 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -55.22 -31.76 61.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.983 -1.008 . . . . 1.3600000000000001 112.568 -179.366 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 1.092 ' OD1' ' CB ' ' A' ' 54' ' ' ASP . 14.2 t70 -76.04 -48.84 19.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.852 0.358 . . . . 1.24 110.616 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.79 -38.27 83.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.189 -0.459 . . . . 0.34000000000000002 111.433 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.597 HD12 ' HB1' ' A' ' 114' ' ' ALA . 22.6 pt -67.77 -31.53 52.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.709 0.29 . . . . 0.65000000000000002 110.339 178.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.15 -42.55 96.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.504 -0.316 . . . . 0.69999999999999996 110.521 174.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 1.288 ' HD2' ' CE1' ' A' ' 58' ' ' TYR . 5.5 m-85 -60.4 -37.83 82.09 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.186 -0.461 . . . . 3.21 110.951 178.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.11 -18.42 65.33 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.951 -0.568 . . . . 0.60999999999999999 111.933 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 1.394 ' NH1' ' NE ' ' A' ' 60' ' ' ARG . 2.0 mtm180 -98.71 7.14 46.43 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.148 0.425 . . . . 3.9199999999999999 112.148 -174.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -179.47 -67.07 0.07 OUTLIER Glycine 0 CA--C 1.474 -2.495 0 C-N-CA 120.043 -1.075 . . . . 1.0700000000000001 115.717 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.19 1.55 0.24 Allowed 'Trans proline' 1 C--O 0.964 -13.197 0 C-N-CA 123.385 2.723 . . . . 1.46 114.116 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 1.494 ' HG3' ' CB ' ' A' ' 63' ' ' GLU 0.324 0.0 OUTLIER -58.67 92.39 0.02 OUTLIER 'General case' 3 C--O 0.284 -49.751 3 O-C-N 111.462 -7.023 . . . . 2.6499999999999999 111.148 176.942 . . . . . . . . 6 4 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 1.58 ' HG3' ' CA ' ' A' ' 64' ' ' GLN 0.892 0.9 OUTLIER -78.62 -33.58 47.23 Favored 'General case' 4 C--O 0.697 -27.995 5 O-C-N 67.284 -34.635 . . . . 6.21 146.622 -165.232 . . . . . . . . 6 4 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 1.66 HD11 ' CG1' ' A' ' 65' ' ' ILE . 1.9 tt -130.22 -31.71 0.68 Allowed 'Isoleucine or valine' 3 C--N 0.847 -21.269 3 O-C-N 97.4 -15.812 . . . . 2.9399999999999999 110.006 -179.801 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.517 ' N ' HG21 ' A' ' 65' ' ' ILE . . . -129.46 147.24 64.35 Favored Pre-proline 1 C--N 1.237 -4.302 0 O-C-N 119.381 -2.074 . . . . 1.3200000000000001 109.724 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.672 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 62.4 Cg_endo -73.25 156.88 50.71 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.353 2.036 . . . . 1.0800000000000001 111.997 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.4 pt -77.16 123.13 33.19 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.382 0 CA-C-O 121.157 0.503 . . . . 0.78000000000000003 110.521 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 1.125 HD23 ' CG ' ' A' ' 69' ' ' LEU . 6.8 tt -86.04 -50.18 7.24 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.647 -0.871 . . . . 1.26 108.647 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.9 p -159.46 140.18 4.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.294 -0.866 . . . . 0.93999999999999995 110.068 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.97 HG22 ' CB ' ' A' ' 71' ' ' ILE . 2.9 tt -113.2 131.86 63.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 116.074 -0.512 . . . . 1.05 110.097 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 1.44 ' CG ' ' CE2' ' A' ' 72' ' ' TYR . 98.5 m-85 -112.22 133.57 54.27 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.309 -0.626 . . . . 2.2799999999999998 109.309 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.977 HG21 ' CG2' ' A' ' 73' ' ' VAL . 30.7 m -128.95 147.52 33.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 121.467 0.651 . . . . 1.01 110.46 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -87.14 104.01 15.94 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.233 -1.025 . . . . 1.8100000000000001 108.233 172.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 1.002 ' OD1' ' CB ' ' A' ' 75' ' ' ASP . 19.3 t70 -56.17 109.7 0.64 Allowed 'General case' 0 C--O 1.192 -1.932 0 O-C-N 125.099 1.5 . . . . 1.4099999999999999 110.617 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 1.73 ' HB2' ' SD ' ' A' ' 76' ' ' MET . 6.7 mtt -156.48 79.5 0.95 Allowed 'General case' 2 C--O 0.724 -26.597 1 CA-C-O 142.525 10.679 . . . . 4.2400000000000002 112.32 -176.557 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 1.512 ' HA2' ' C ' ' A' ' 77' ' ' GLY . . . -167.92 78.91 0.11 Allowed Glycine 4 C--N 0.689 -35.403 5 O-C-N 83.498 -24.501 . . . . 3.27 145.659 -179.783 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 1.606 ' HB3' ' CA ' ' A' ' 78' ' ' ALA 0.784 . . -101.08 124.05 46.2 Favored 'General case' 4 C--N 0.444 -38.802 4 CA-C-N 83.753 -16.223 . . . . 3.8700000000000001 127.545 -176.277 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 1.584 ' HB3' ' CA ' ' A' ' 79' ' ' ALA 0.513 . . 79.87 -5.5 1.86 Allowed 'General case' 4 C--N 0.627 -30.836 4 O-C-N 74.446 -30.159 . . . . 3.71 121.411 -178.061 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.869 ' H ' ' C ' ' A' ' 78' ' ' ALA . . . -161.77 -52.49 0.02 OUTLIER Glycine 4 N--CA 1.097 -23.932 3 C-N-CA 105.141 -8.171 . . . . 2.98 126.512 179.646 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' A' ' 80' ' ' GLY 0.389 . . 52.65 50.64 17.72 Favored 'General case' 3 C--N 1.051 -12.4 0 CA-C-O 126.119 2.866 . . . . 2.4100000000000001 113.088 -179.086 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 1.326 HG22 ' CB ' ' A' ' 82' ' ' THR 0.321 7.8 p -90.36 176.84 6.58 Favored 'General case' 4 CA--C 1.254 -10.419 1 CA-C-N 107.912 -4.222 . . . . 2.48 107.317 -177.655 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 1.643 ' HZ3' ' CE3' ' A' ' 83' ' ' TRP . 4.0 p90 -57.78 -26.69 62.26 Favored 'General case' 4 N--CA 1.207 -12.608 0 O-C-N 129.042 3.964 . . . . 4.54 108.385 175.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 1.195 ' OD1' ' CB ' ' A' ' 84' ' ' ASP 0.264 8.1 t70 -81.78 -31.19 31.98 Favored 'General case' 3 C--N 1.121 -9.347 1 CA-C-O 128.614 4.055 . . . . 3.1600000000000001 117.227 176.33 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 1.395 ' OE1' ' CG ' ' A' ' 85' ' ' GLN 0.376 8.9 mt-30 61.77 160.3 0.11 Allowed Pre-proline 4 C--O 1.009 -11.58 1 N-CA-C 124.946 5.165 . . . . 3.8500000000000001 124.946 176.554 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.626 ' CD ' ' HB3' ' A' ' 85' ' ' GLN 0.314 10.3 Cg_endo -79.24 -17.99 11.37 Favored 'Trans proline' 4 N--CA 1.323 -8.551 1 C-N-CA 127.532 5.488 . . . . 1.99 120.527 175.244 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.953 ' O ' ' CE ' ' A' ' 76' ' ' MET . . . 131.27 -162.27 23.63 Favored Glycine 4 C--O 0.763 -29.309 0 CA-C-O 127.31 3.728 . . . . 1.8999999999999999 115.315 -178.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 1.639 ' HB2' ' CA ' ' A' ' 88' ' ' ASP 0.696 4.4 m-20 -75.22 142.79 43.36 Favored 'General case' 4 C--O 0.632 -31.432 5 O-C-N 98.011 -14.817 . . . . 4.79 134.136 177.642 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -143.55 -152.84 5.73 Favored Glycine 3 N--CA 1.038 -27.887 3 N-CA-C 138.022 9.969 . . . . 1.6299999999999999 138.022 -176.037 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 75' ' ' ASP . 16.7 m-20 -95.66 149.79 21.08 Favored 'General case' 0 C--O 1.158 -3.75 0 O-C-N 121.724 -0.868 . . . . 3.2400000000000002 111.467 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 1.63 ' HZ3' ' CD1' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -101.95 129.24 48.18 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 119.964 1.256 . . . . 4.8799999999999999 110.683 179.041 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 1.01 HG21 ' CB ' ' A' ' 92' ' ' ILE . 13.2 pt -143.19 162.01 17.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.013 -0.54 . . . . 1.1399999999999999 111.539 -175.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.69 108.46 18.04 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.546 -0.539 . . . . 0.68999999999999995 109.546 172.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 1.006 ' HB3' ' CA ' ' A' ' 94' ' ' ALA . . . -64.67 -35.3 80.57 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.43 -0.35 . . . . 1.1100000000000001 111.686 -174.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 1.404 ' OD1' ' CB ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -64.0 -23.93 67.52 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-O 121.671 0.748 . . . . 1.4399999999999999 110.548 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 1.28 ' HZ2' ' CE ' ' A' ' 96' ' ' LYS . 38.1 mmtm -111.93 33.06 5.03 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.108 -0.951 . . . . 1.49 110.621 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.94 -179.74 5.67 Favored 'General case' 0 C--N 1.311 -1.092 0 O-C-N 121.745 -0.597 . . . . 0.39000000000000001 111.022 -172.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 1.402 ' CZ ' ' CD2' ' A' ' 98' ' ' PHE . 97.4 m-85 -93.97 136.98 33.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.423 0.63 . . . . 2.0899999999999999 110.355 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.517 ' CZ ' ' CD1' ' A' ' 99' ' ' TYR . 2.8 m-85 -120.48 135.74 54.97 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.248 -0.887 . . . . 2.2400000000000002 109.785 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 p -114.69 124.3 71.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.558 0.694 . . . . 0.90000000000000002 109.893 172.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 49.0 t -102.19 111.47 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 114.786 -1.097 . . . . 0.80000000000000004 108.567 176.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.58 125.96 8.28 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.748 -0.739 . . . . 0.67000000000000004 112.743 -175.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 1.073 ' CB ' ' OG ' ' A' ' 103' ' ' SER . 3.3 m -91.67 -29.83 16.65 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 120.896 0.379 . . . . 1.6699999999999999 110.646 177.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.93 -43.2 18.43 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.241 -0.436 . . . . 1.4099999999999999 111.259 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 1.5 ' CD ' ' CZ ' ' A' ' 105' ' ' ARG . 59.6 mtp180 -128.14 107.29 9.68 Favored 'General case' 1 C--O 0.621 -32.021 1 CA-C-O 129.716 4.579 . . . . 3.21 111.079 178.52 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 1.647 ' HD2' ' CZ ' ' A' ' 106' ' ' ARG . 3.1 tpm_? -171.6 -137.82 0.02 OUTLIER 'General case' 2 C--O 0.637 -31.168 4 O-C-N 84.441 -23.912 . . . . 5.6600000000000001 114.742 177.331 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.826 ' O ' ' N ' ' A' ' 109' ' ' MET . . . -109.14 -22.21 6.97 Favored Glycine 4 C--O 0.812 -26.256 3 O-C-N 86.792 -22.442 . . . . 1.7 119.796 -179.371 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 17.4 -65.41 0.0 OUTLIER Glycine 4 C--N 0.906 -23.342 2 O-C-N 108.068 -8.901 . . . . 2.1099999999999999 119.78 179.839 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 1.646 ' HB3' ' SD ' ' A' ' 109' ' ' MET . 40.0 mtm -97.74 2.02 49.11 Favored 'General case' 4 C--N 1.164 -7.492 0 O-C-N 117.067 -3.608 . . . . 5.6299999999999999 114.983 177.167 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -130.86 -121.95 2.35 Favored Glycine 4 C--N 1.104 -12.34 0 CA-C-N 110.675 -2.966 . . . . 1.6100000000000001 111.154 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -104.69 99.97 21.03 Favored Pre-proline 0 N--CA 1.392 -3.368 0 CA-C-N 118.797 1.299 . . . . 1.8 113.101 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -63.96 139.75 69.28 Favored 'Trans proline' 0 C--N 1.274 -3.373 0 C-N-CA 123.247 2.631 . . . . 1.23 114.025 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.877 ' O ' ' CZ ' ' A' ' 106' ' ' ARG . 42.7 mt-10 -117.12 136.32 53.1 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.711 -0.677 . . . . 2.1600000000000001 110.341 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.597 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -104.84 131.2 52.62 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 122.347 0.259 . . . . 0.46999999999999997 110.698 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 1.441 HG23 ' CB ' ' A' ' 115' ' ' VAL . 87.2 t -100.76 105.7 39.31 Favored Pre-proline 0 C--N 1.316 -0.89 0 C-N-CA 120.21 -0.596 . . . . 1.5900000000000001 110.077 174.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.526 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 5.9 Cg_exo -87.87 124.04 1.8 Allowed 'Trans proline' 0 C--O 1.212 -0.775 0 C-N-CA 123.819 3.012 . . . . 0.46999999999999997 112.195 177.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 1.6 ' HE1' ' CE2' ' A' ' 117' ' ' PHE . 0.5 OUTLIER -128.12 150.09 50.13 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 122.431 0.292 . . . . 3.0299999999999998 110.57 -179.201 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 1.275 ' HG ' ' CB ' ' A' ' 118' ' ' SER . 32.2 t -80.22 -30.26 38.6 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.205 0.526 . . . . 1.3700000000000001 110.32 175.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 1.147 ' HG ' ' CB ' ' A' ' 119' ' ' SER . 16.3 m -98.15 122.29 41.11 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.051 -0.522 . . . . 1.3 110.618 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -61.61 -45.2 95.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.071 0.462 . . . . 1.8899999999999999 111.423 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 1.014 ' OD2' ' CB ' ' A' ' 121' ' ' ASP . 54.2 p30 -63.49 -29.6 70.85 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.717 -0.674 . . . . 1.3100000000000001 110.981 -173.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.954 ' OE1' ' CG ' ' A' ' 122' ' ' GLU . 32.2 mm-40 -67.78 -41.13 83.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.067 -0.515 . . . . 1.25 110.596 174.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.07 -36.55 80.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.198 0.523 . . . . 1.04 110.146 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.94 -38.78 86.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.678 -0.692 . . . . 0.5 111.041 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.986 ' HB1' ' CB ' ' A' ' 125' ' ' ALA . . . -62.32 -34.84 77.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.315 -0.402 . . . . 1.1000000000000001 110.649 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 1.52 ' CZ ' ' CD1' ' A' ' 126' ' ' PHE . 44.1 t80 -62.72 -39.7 94.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.144 -0.48 . . . . 2.3799999999999999 109.841 175.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.587 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 75.3 t -70.36 -33.39 53.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 CA-C-N 115.922 -0.581 . . . . 0.85999999999999999 110.686 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 1.634 HD13 ' CG ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -57.69 -40.77 80.24 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.268 0.556 . . . . 2.3599999999999999 110.491 177.214 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 1.013 ' HB1' ' CA ' ' A' ' 129' ' ' ALA . . . -81.12 -46.8 14.4 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.901 -0.59 . . . . 1.3899999999999999 110.761 177.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 1.151 ' OE2' ' CG ' ' A' ' 130' ' ' GLU . 8.8 pt-20 -154.23 -73.79 0.12 Allowed 'General case' 1 C--O 1.105 -6.509 0 CA-C-O 123.096 1.426 . . . . 1.8999999999999999 111.515 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.741 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 24.02 -152.68 0.0 OUTLIER Glycine 2 C--O 1.033 -12.438 0 O-C-N 117.498 -3.251 . . . . 1.02 114.54 176.127 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -159.33 -83.79 0.05 OUTLIER Glycine 1 C--N 1.233 -5.178 0 CA-C-N 123.81 3.805 . . . . 0.79000000000000004 111.525 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 1.304 ' NE2' ' CG ' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -129.29 142.81 50.73 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.721 0.296 . . . . 1.8500000000000001 110.763 177.36 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.6 116.01 45.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.063 -0.517 . . . . 0.87 109.844 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 1.003 HD23 ' CG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -139.71 161.3 37.87 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.762 -0.653 . . . . 1.25 109.986 -178.357 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.8 164.38 17.6 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.921 -0.487 . . . . 0.57999999999999996 109.719 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.853 HD12 ' HA ' ' A' ' 95' ' ' ASP . 1.8 tt -62.5 -33.25 74.5 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.477 0.656 . . . . 1.73 110.036 178.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.84 -13.8 62.17 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.385 -0.825 . . . . 1.0 111.36 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 1.238 ' OD2' ' CB ' ' A' ' 139' ' ' ASP . 5.1 t70 -117.86 17.65 14.18 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.112 0.482 . . . . 1.73 110.994 -175.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.435 HD11 HD12 ' A' ' 135' ' ' LEU . 32.4 mm -72.05 121.87 23.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.334 0.588 . . . . 1.0 109.965 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.1 t -113.86 147.77 37.85 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.746 -0.661 . . . . 1.1399999999999999 109.842 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 1.048 ' OD2' ' CB ' ' A' ' 142' ' ' ASP . 6.4 p-10 -69.41 -29.36 67.07 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.372 -0.376 . . . . 1.55 111.225 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.92 -29.06 69.96 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.101 -0.5 . . . . 1.3 111.648 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 1.732 ' HE1' ' SD ' ' A' ' 144' ' ' MET . 21.5 mmt -82.42 -32.9 28.81 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-O 120.766 0.317 . . . . 2.3500000000000001 111.477 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 1.067 HG12 ' CB ' ' A' ' 145' ' ' VAL . 5.6 t -85.56 -22.5 7.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 116.536 -0.302 . . . . 1.6799999999999999 110.814 -174.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 1.263 HD22 ' CG ' ' A' ' 146' ' ' LEU . 4.2 pp -155.43 139.7 16.64 Favored 'General case' 0 C--O 1.193 -1.892 0 CA-C-O 121.451 0.643 . . . . 1.9199999999999999 110.951 -176.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.6 p -107.37 126.59 29.67 Favored Pre-proline 0 C--N 1.269 -2.928 0 CA-C-O 121.834 0.826 . . . . 1.9199999999999999 111.086 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -66.63 -68.49 0.03 OUTLIER 'Trans proline' 3 C--O 1.095 -6.661 0 CA-C-O 124.247 1.686 . . . . 2.2799999999999998 112.34 176.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 1.247 HG23 ' CB ' ' A' ' 149' ' ' VAL . 4.0 t -133.7 2.43 1.36 Allowed 'Isoleucine or valine' 4 C--O 0.957 -14.293 0 O-C-N 118.548 -2.595 . . . . 3.7799999999999998 109.349 176.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 1.277 ' OE2' ' CG ' ' A' ' 150' ' ' GLU . 36.9 mt-10 66.42 -44.28 0.42 Allowed 'General case' 3 C--O 0.745 -25.482 1 CA-C-O 131.389 5.376 . . . . 3.2799999999999998 110.427 -173.197 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 1.448 HG23 ' CB ' ' A' ' 151' ' ' THR . 3.4 t 10.28 -0.8 0.0 OUTLIER 'General case' 4 C--N 0.914 -18.363 3 O-C-N 93.59 -18.194 . . . . 4.0499999999999998 112.54 177.95 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.829 ' N ' ' O ' ' A' ' 150' ' ' GLU . . . 77.72 50.79 6.28 Favored Glycine 4 CA--C 1.253 -16.323 1 N-CA-C 137.27 9.668 . . . . 4.1399999999999997 137.27 -178.531 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 1.393 ' OG ' ' CA ' ' A' ' 153' ' ' SER 0.33 1.4 m -101.64 147.29 26.6 Favored 'General case' 4 N--CA 1.195 -13.181 0 CA-C-N 113.28 -1.46 . . . . 3.54 113.129 -179.731 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.235 ' HG3' ' OE1' ' A' ' 154' ' ' GLU . 0.6 OUTLIER -65.41 135.83 96.06 Favored Pre-proline 3 C--O 1.078 -7.97 0 N-CA-C 115.094 1.516 . . . . 3.27 115.094 179.214 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.471 ' CB ' ' CE ' ' A' ' 144' ' ' MET . 14.3 Cg_endo -62.91 -72.61 0.02 OUTLIER 'Trans proline' 3 C--O 0.877 -17.563 1 C-N-CA 127.053 5.169 . . . . 2.2400000000000002 114.279 -176.828 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 1.563 ' CZ ' ' CD ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -107.39 -45.76 4.01 Favored 'General case' 3 C--N 0.99 -15.051 2 O-C-N 106.061 -10.4 . . . . 4.5499999999999998 109.808 177.587 . . . . . . . . 5 4 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 1.291 ' C ' ' CA ' ' A' ' 158' ' ' ASP . . . -169.58 33.85 0.02 OUTLIER 'General case' 4 C--O 0.763 -24.505 1 CA-C-O 134.423 6.82 . . . . 3.0699999999999998 109.332 -179.435 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 1.291 ' CA ' ' C ' ' A' ' 157' ' ' ALA . 16.9 t0 57.86 45.87 17.75 Favored 'General case' 4 C--O 0.786 -23.326 3 O-C-N 94.029 -17.92 . . . . 3.9900000000000002 105.535 -169.219 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 1.342 ' C ' ' H ' ' A' ' 160' ' ' GLU 0.414 18.9 t70 -104.93 -81.74 0.53 Allowed 'General case' 4 C--O 0.445 -41.259 3 O-C-N 108.9 -8.625 . . . . 4.3200000000000003 121.657 -171.744 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 1.573 ' HA ' ' CG ' ' A' ' 160' ' ' GLU 0.93 0.5 OUTLIER . . . . . 4 C--O 0.43 -42.074 4 O-C-N 94.248 -17.782 . . . . 4.7400000000000002 118.837 178.987 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.5 tttt . . . . . 0 C--O 1.212 -0.894 0 N-CA-C 109.975 -0.38 . . . . 1.95 109.975 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -136.85 144.27 43.5 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 118.015 0.37 . . . . 0.33000000000000002 111.231 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 1.188 ' NE2' ' CG ' ' A' ' 37' ' ' GLN . 13.4 pt20 -148.48 135.33 19.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.28 -0.418 . . . . 1.3999999999999999 110.185 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.461 HG21 ' HB2' ' A' ' 59' ' ' ALA . 30.9 pt -116.71 135.77 55.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.037 0.446 . . . . 0.46000000000000002 110.997 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 1.57 ' CZ ' ' CD1' ' A' ' 39' ' ' PHE . 40.9 t80 -104.38 122.56 45.72 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.298 -0.63 . . . . 1.7 109.298 176.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.693 HD23 ' HB3' ' A' ' 66' ' ' ALA . 9.6 mp -91.11 146.51 23.78 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.106 -0.497 . . . . 0.88 111.286 -176.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 1.068 ' OE1' ' CG ' ' A' ' 41' ' ' GLU . 36.6 tt0 -73.71 125.45 28.11 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.719 -0.475 . . . . 1.49 109.719 178.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.38 -27.28 8.72 Favored Glycine 0 C--O 1.184 -3.025 0 C-N-CA 120.713 -0.756 . . . . 1.3300000000000001 111.957 -177.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.52 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 13.1 t -92.06 125.87 55.24 Favored Pre-proline 0 C--N 1.285 -2.234 0 O-C-N 121.236 -1.155 . . . . 1.1100000000000001 110.258 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.52 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 4.2 Cg_exo -80.9 0.44 10.02 Favored 'Trans proline' 0 N--CA 1.44 -1.632 0 C-N-CA 123.504 2.802 . . . . 1.3400000000000001 112.913 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -118.68 134.4 23.53 Favored Pre-proline 0 C--N 1.296 -1.722 0 O-C-N 121.875 -0.516 . . . . 1.1000000000000001 111.709 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 31.0 Cg_endo -90.58 146.1 4.01 Favored 'Trans proline' 0 N--CA 1.44 -1.642 0 C-N-CA 123.499 2.799 . . . . 0.81999999999999995 112.367 176.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.442 ' HB3' HG12 ' A' ' 38' ' ' ILE . 6.9 tt -96.23 113.36 24.95 Favored 'General case' 0 C--N 1.285 -2.216 0 O-C-N 121.507 -0.746 . . . . 1.03 109.021 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -111.81 140.61 46.31 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.675 0.274 . . . . 2.1800000000000002 111.584 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 1.634 ' CG ' ' CE2' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -146.41 145.35 30.22 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 116.077 -0.51 . . . . 1.97 109.886 177.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 m -63.32 -42.2 98.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.142 0.496 . . . . 1.1399999999999999 110.782 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 1.068 ' NE2' ' CG ' ' A' ' 51' ' ' GLN . 60.0 mt-30 -76.54 114.41 15.23 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.265 -0.425 . . . . 1.3600000000000001 110.552 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.603 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 14.5 t -62.72 -50.6 79.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.138 0.494 . . . . 0.48999999999999999 109.789 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.61 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -55.22 -31.76 61.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.983 -1.008 . . . . 1.2 112.568 -179.366 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 1.092 ' OD1' ' CB ' ' A' ' 54' ' ' ASP . 14.2 t70 -76.04 -48.84 19.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.852 0.358 . . . . 1.24 110.616 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 36' ' ' ALA . . . -67.79 -38.27 83.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.189 -0.459 . . . . 0.34000000000000002 111.433 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.587 ' CD1' ' HB3' ' A' ' 114' ' ' ALA . 22.6 pt -67.77 -31.53 52.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.709 0.29 . . . . 0.42999999999999999 110.339 178.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.15 -42.55 96.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.504 -0.316 . . . . 0.51000000000000001 110.521 174.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -60.4 -37.83 82.09 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.186 -0.461 . . . . 2.7599999999999998 110.951 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.461 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -66.11 -18.42 65.33 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.951 -0.568 . . . . 0.60999999999999999 111.933 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 1.394 ' NH1' ' NE ' ' A' ' 60' ' ' ARG . 2.0 mtm180 -98.71 7.14 46.43 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.148 0.425 . . . . 3.3199999999999998 112.148 -174.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -179.47 -67.07 0.07 OUTLIER Glycine 0 CA--C 1.474 -2.495 0 C-N-CA 120.043 -1.075 . . . . 0.90000000000000002 115.717 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.19 1.55 0.24 Allowed 'Trans proline' 1 C--O 0.964 -13.197 0 C-N-CA 123.385 2.723 . . . . 1.46 114.116 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . 0.324 0.0 OUTLIER -58.67 92.39 0.02 OUTLIER 'General case' 3 C--O 0.284 -49.751 3 O-C-N 111.462 -7.023 . . . . 2.6499999999999999 111.148 176.942 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 1.322 ' C ' ' CA ' ' A' ' 65' ' ' ILE 0.892 0.9 OUTLIER -78.62 -33.58 47.23 Favored 'General case' 4 C--O 0.697 -27.995 5 O-C-N 67.284 -34.635 . . . . 5.5499999999999998 146.622 -165.232 . . . . . . . . 6 4 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 1.322 ' CA ' ' C ' ' A' ' 64' ' ' GLN . 1.9 tt -130.22 -31.71 0.68 Allowed 'Isoleucine or valine' 3 C--N 0.847 -21.269 3 O-C-N 97.4 -15.812 . . . . 2.4900000000000002 110.006 -179.801 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.693 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -129.46 147.24 64.35 Favored Pre-proline 1 C--N 1.237 -4.302 0 O-C-N 119.381 -2.074 . . . . 1.2 109.724 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.726 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 62.4 Cg_endo -73.25 156.88 50.71 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.353 2.036 . . . . 0.97999999999999998 111.997 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.4 pt -77.16 123.13 33.19 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.382 0 CA-C-O 121.157 0.503 . . . . 0.77000000000000002 110.521 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.8 tt -86.04 -50.18 7.24 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.647 -0.871 . . . . 0.72999999999999998 108.647 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.9 p -159.46 140.18 4.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.294 -0.866 . . . . 0.40000000000000002 110.068 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.467 HD11 HG22 ' A' ' 56' ' ' ILE . 2.9 tt -113.2 131.86 63.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 116.074 -0.512 . . . . 0.34000000000000002 110.097 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 1.44 ' CG ' ' CE2' ' A' ' 72' ' ' TYR . 98.5 m-85 -112.22 133.57 54.27 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.309 -0.626 . . . . 1.3500000000000001 109.309 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.425 HG22 ' HB2' ' A' ' 94' ' ' ALA . 30.7 m -128.95 147.52 33.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 121.467 0.651 . . . . 0.29999999999999999 110.46 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -87.14 104.01 15.94 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.233 -1.025 . . . . 1.76 108.233 172.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 1.002 ' OD1' ' CB ' ' A' ' 75' ' ' ASP . 19.3 t70 -56.17 109.7 0.64 Allowed 'General case' 0 C--O 1.192 -1.932 0 O-C-N 125.099 1.5 . . . . 1.4099999999999999 110.617 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . 1.435 ' C ' ' CA ' ' A' ' 77' ' ' GLY . 6.7 mtt -156.48 79.5 0.95 Allowed 'General case' 2 C--O 0.724 -26.597 1 CA-C-O 142.525 10.679 . . . . 3.8500000000000001 112.32 -176.557 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 1.435 ' CA ' ' C ' ' A' ' 76' ' ' MET . . . -167.92 78.91 0.11 Allowed Glycine 4 C--N 0.689 -35.403 5 O-C-N 83.498 -24.501 . . . . 3.02 145.659 -179.783 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 1.466 ' C ' ' CA ' ' A' ' 79' ' ' ALA 0.784 . . -101.08 124.05 46.2 Favored 'General case' 4 C--N 0.444 -38.802 4 CA-C-N 83.753 -16.223 . . . . 3.4199999999999999 127.545 -176.277 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 1.466 ' CA ' ' C ' ' A' ' 78' ' ' ALA 0.513 . . 79.87 -5.5 1.86 Allowed 'General case' 4 C--N 0.627 -30.836 4 O-C-N 74.446 -30.159 . . . . 3.2599999999999998 121.411 -178.061 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.859 ' N ' ' C ' ' A' ' 78' ' ' ALA . . . -161.77 -52.49 0.02 OUTLIER Glycine 4 N--CA 1.097 -23.932 3 C-N-CA 105.141 -8.171 . . . . 2.54 126.512 179.646 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 80' ' ' GLY 0.389 . . 52.65 50.64 17.72 Favored 'General case' 3 C--N 1.051 -12.4 0 CA-C-O 126.119 2.866 . . . . 2.02 113.088 -179.086 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.812 ' O ' ' HG2' ' A' ' 85' ' ' GLN 0.321 7.8 p -90.36 176.84 6.58 Favored 'General case' 4 CA--C 1.254 -10.419 1 CA-C-N 107.912 -4.222 . . . . 2.0299999999999998 107.317 -177.655 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 4.0 p90 -57.78 -26.69 62.26 Favored 'General case' 4 N--CA 1.207 -12.608 0 O-C-N 129.042 3.964 . . . . 3.79 108.385 175.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 1.195 ' OD1' ' CB ' ' A' ' 84' ' ' ASP 0.264 8.1 t70 -81.78 -31.19 31.98 Favored 'General case' 3 C--N 1.121 -9.347 1 CA-C-O 128.614 4.055 . . . . 3.1600000000000001 117.227 176.33 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 1.395 ' OE1' ' CG ' ' A' ' 85' ' ' GLN 0.376 8.9 mt-30 61.77 160.3 0.11 Allowed Pre-proline 4 C--O 1.009 -11.58 1 N-CA-C 124.946 5.165 . . . . 3.3799999999999999 124.946 176.554 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.775 ' HD2' ' HB3' ' A' ' 85' ' ' GLN 0.314 10.3 Cg_endo -79.24 -17.99 11.37 Favored 'Trans proline' 4 N--CA 1.323 -8.551 1 C-N-CA 127.532 5.488 . . . . 1.99 120.527 175.244 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.953 ' O ' ' CE ' ' A' ' 76' ' ' MET . . . 131.27 -162.27 23.63 Favored Glycine 4 C--O 0.763 -29.309 0 CA-C-O 127.31 3.728 . . . . 1.6799999999999999 115.315 -178.557 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.514 ' HA ' ' HE1' ' A' ' 76' ' ' MET 0.696 4.4 m-20 -75.22 142.79 43.36 Favored 'General case' 4 C--O 0.632 -31.432 5 O-C-N 98.011 -14.817 . . . . 4.79 134.136 177.642 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . -143.55 -152.84 5.73 Favored Glycine 3 N--CA 1.038 -27.887 3 N-CA-C 138.022 9.969 . . . . 1.25 138.022 -176.037 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 75' ' ' ASP . 16.7 m-20 -95.66 149.79 21.08 Favored 'General case' 0 C--O 1.158 -3.75 0 O-C-N 121.724 -0.868 . . . . 2.6099999999999999 111.467 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.662 ' CE2' ' HZ3' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -101.95 129.24 48.18 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 119.964 1.256 . . . . 3.9399999999999999 110.683 179.041 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.852 HG21 ' HB2' ' A' ' 118' ' ' SER . 13.2 pt -143.19 162.01 17.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.013 -0.54 . . . . 0.53000000000000003 111.539 -175.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.69 108.46 18.04 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.546 -0.539 . . . . 0.34999999999999998 109.546 172.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -64.67 -35.3 80.57 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.43 -0.35 . . . . 0.34000000000000002 111.686 -174.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 1.404 ' OD1' ' CB ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -64.0 -23.93 67.52 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-O 121.671 0.748 . . . . 1.4399999999999999 110.548 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -111.93 33.06 5.03 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.108 -0.951 . . . . 1.0800000000000001 110.621 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.94 -179.74 5.67 Favored 'General case' 0 C--N 1.311 -1.092 0 O-C-N 121.745 -0.597 . . . . 0.34999999999999998 111.022 -172.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 1.402 ' CZ ' ' CD2' ' A' ' 98' ' ' PHE . 97.4 m-85 -93.97 136.98 33.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.423 0.63 . . . . 1.24 110.355 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 1.517 ' CZ ' ' CD1' ' A' ' 99' ' ' TYR . 2.8 m-85 -120.48 135.74 54.97 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.248 -0.887 . . . . 1.3799999999999999 109.785 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.52 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.5 p -114.69 124.3 71.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.558 0.694 . . . . 0.35999999999999999 109.893 172.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.41 HG23 HD11 ' A' ' 135' ' ' LEU . 49.0 t -102.19 111.47 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 114.786 -1.097 . . . . 0.56000000000000005 108.567 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.58 125.96 8.28 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.748 -0.739 . . . . 0.67000000000000004 112.743 -175.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . 1.073 ' CB ' ' OG ' ' A' ' 103' ' ' SER . 3.3 m -91.67 -29.83 16.65 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 120.896 0.379 . . . . 1.4299999999999999 110.646 177.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.93 -43.2 18.43 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.241 -0.436 . . . . 0.96999999999999997 111.259 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 1.5 ' CD ' ' CZ ' ' A' ' 105' ' ' ARG . 59.6 mtp180 -128.14 107.29 9.68 Favored 'General case' 1 C--O 0.621 -32.021 1 CA-C-O 129.716 4.579 . . . . 2.8300000000000001 111.079 178.52 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.877 ' CZ ' ' O ' ' A' ' 113' ' ' GLU . 3.1 tpm_? -171.6 -137.82 0.02 OUTLIER 'General case' 2 C--O 0.637 -31.168 4 O-C-N 84.441 -23.912 . . . . 5.0199999999999996 114.742 177.331 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.826 ' O ' ' N ' ' A' ' 109' ' ' MET . . . -109.14 -22.21 6.97 Favored Glycine 4 C--O 0.812 -26.256 3 O-C-N 86.792 -22.442 . . . . 1.7 119.796 -179.371 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 17.4 -65.41 0.0 OUTLIER Glycine 4 C--N 0.906 -23.342 2 O-C-N 108.068 -8.901 . . . . 2.1099999999999999 119.78 179.839 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . 1.525 ' CG ' ' CA ' ' A' ' 109' ' ' MET . 40.0 mtm -97.74 2.02 49.11 Favored 'General case' 4 C--N 1.164 -7.492 0 O-C-N 117.067 -3.608 . . . . 5.0999999999999996 114.983 177.167 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -130.86 -121.95 2.35 Favored Glycine 4 C--N 1.104 -12.34 0 CA-C-N 110.675 -2.966 . . . . 1.54 111.154 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.461 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -104.69 99.97 21.03 Favored Pre-proline 0 N--CA 1.392 -3.368 0 CA-C-N 118.797 1.299 . . . . 1.4399999999999999 113.101 177.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 27.3 Cg_endo -63.96 139.75 69.28 Favored 'Trans proline' 0 C--N 1.274 -3.373 0 C-N-CA 123.247 2.631 . . . . 1.0600000000000001 114.025 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.877 ' O ' ' CZ ' ' A' ' 106' ' ' ARG . 42.7 mt-10 -117.12 136.32 53.1 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.711 -0.677 . . . . 2.1600000000000001 110.341 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.587 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . . . -104.84 131.2 52.62 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 122.347 0.259 . . . . 0.40999999999999998 110.698 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.52 ' HB ' HG13 ' A' ' 100' ' ' VAL . 87.2 t -100.76 105.7 39.31 Favored Pre-proline 0 C--N 1.316 -0.89 0 C-N-CA 120.21 -0.596 . . . . 0.93000000000000005 110.077 174.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 5.9 Cg_exo -87.87 124.04 1.8 Allowed 'Trans proline' 0 C--O 1.212 -0.775 0 C-N-CA 123.819 3.012 . . . . 0.46999999999999997 112.195 177.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -128.12 150.09 50.13 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 122.431 0.292 . . . . 2.1899999999999999 110.57 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.852 ' HB2' HG21 ' A' ' 92' ' ' ILE . 32.2 t -80.22 -30.26 38.6 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.205 0.526 . . . . 0.81000000000000005 110.32 175.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 16.3 m -98.15 122.29 41.11 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.051 -0.522 . . . . 0.65000000000000002 110.618 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -61.61 -45.2 95.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.071 0.462 . . . . 1.48 111.423 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 1.014 ' OD2' ' CB ' ' A' ' 121' ' ' ASP . 54.2 p30 -63.49 -29.6 70.85 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.717 -0.674 . . . . 1.3100000000000001 110.981 -173.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.954 ' OE1' ' CG ' ' A' ' 122' ' ' GLU . 32.2 mm-40 -67.78 -41.13 83.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.067 -0.515 . . . . 1.25 110.596 174.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.07 -36.55 80.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.198 0.523 . . . . 0.28999999999999998 110.146 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.94 -38.78 86.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.678 -0.692 . . . . 0.32000000000000001 111.041 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.32 -34.84 77.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.315 -0.402 . . . . 0.45000000000000001 110.649 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 1.52 ' CZ ' ' CD1' ' A' ' 126' ' ' PHE . 44.1 t80 -62.72 -39.7 94.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.144 -0.48 . . . . 1.5 109.841 175.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.623 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 75.3 t -70.36 -33.39 53.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 CA-C-N 115.922 -0.581 . . . . 0.59999999999999998 110.686 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 1.453 ' CD2' ' CB ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -57.69 -40.77 80.24 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.268 0.556 . . . . 1.74 110.491 177.214 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.12 -46.8 14.4 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.901 -0.59 . . . . 0.97999999999999998 110.761 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 1.151 ' OE2' ' CG ' ' A' ' 130' ' ' GLU . 8.8 pt-20 -154.23 -73.79 0.12 Allowed 'General case' 1 C--O 1.105 -6.509 0 CA-C-O 123.096 1.426 . . . . 1.8999999999999999 111.515 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.834 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 24.02 -152.68 0.0 OUTLIER Glycine 2 C--O 1.033 -12.438 0 O-C-N 117.498 -3.251 . . . . 1.02 114.54 176.127 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.455 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -159.33 -83.79 0.05 OUTLIER Glycine 1 C--N 1.233 -5.178 0 CA-C-N 123.81 3.805 . . . . 0.51000000000000001 111.525 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 1.304 ' NE2' ' CG ' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -129.29 142.81 50.73 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.721 0.296 . . . . 1.6599999999999999 110.763 177.36 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.6 116.01 45.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.063 -0.517 . . . . 0.42999999999999999 109.844 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.849 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -139.71 161.3 37.87 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.762 -0.653 . . . . 0.51000000000000001 109.986 -178.357 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.8 164.38 17.6 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.921 -0.487 . . . . 0.53000000000000003 109.719 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.866 HD13 ' HA ' ' A' ' 95' ' ' ASP . 1.8 tt -62.5 -33.25 74.5 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.477 0.656 . . . . 1.26 110.036 178.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.84 -13.8 62.17 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.385 -0.825 . . . . 0.90000000000000002 111.36 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 1.238 ' OD2' ' CB ' ' A' ' 139' ' ' ASP . 5.1 t70 -117.86 17.65 14.18 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.112 0.482 . . . . 1.73 110.994 -175.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.849 HD13 HD13 ' A' ' 135' ' ' LEU . 32.4 mm -72.05 121.87 23.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.334 0.588 . . . . 0.75 109.965 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.1 t -113.86 147.77 37.85 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.746 -0.661 . . . . 0.80000000000000004 109.842 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 1.048 ' OD2' ' CB ' ' A' ' 142' ' ' ASP . 6.4 p-10 -69.41 -29.36 67.07 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.372 -0.376 . . . . 1.55 111.225 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.92 -29.06 69.96 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.101 -0.5 . . . . 0.87 111.648 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . 1.092 ' SD ' ' CE ' ' A' ' 144' ' ' MET . 21.5 mmt -82.42 -32.9 28.81 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-O 120.766 0.317 . . . . 1.7 111.477 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 5.6 t -85.56 -22.5 7.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 116.536 -0.302 . . . . 1.1699999999999999 110.814 -174.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.2 pp -155.43 139.7 16.64 Favored 'General case' 0 C--O 1.193 -1.892 0 CA-C-O 121.451 0.643 . . . . 1.54 110.951 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.6 p -107.37 126.59 29.67 Favored Pre-proline 0 C--N 1.269 -2.928 0 CA-C-O 121.834 0.826 . . . . 1.6699999999999999 111.086 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -66.63 -68.49 0.03 OUTLIER 'Trans proline' 3 C--O 1.095 -6.661 0 CA-C-O 124.247 1.686 . . . . 2.1499999999999999 112.34 176.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 149' ' ' VAL . 4.0 t -133.7 2.43 1.36 Allowed 'Isoleucine or valine' 4 C--O 0.957 -14.293 0 O-C-N 118.548 -2.595 . . . . 3.3900000000000001 109.349 176.41 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 1.277 ' OE2' ' CG ' ' A' ' 150' ' ' GLU . 36.9 mt-10 66.42 -44.28 0.42 Allowed 'General case' 3 C--O 0.745 -25.482 1 CA-C-O 131.389 5.376 . . . . 3.2799999999999998 110.427 -173.197 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.4 t 10.28 -0.8 0.0 OUTLIER 'General case' 4 C--N 0.914 -18.363 3 O-C-N 93.59 -18.194 . . . . 3.9300000000000002 112.54 177.95 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.829 ' N ' ' O ' ' A' ' 150' ' ' GLU . . . 77.72 50.79 6.28 Favored Glycine 4 CA--C 1.253 -16.323 1 N-CA-C 137.27 9.668 . . . . 3.7200000000000002 137.27 -178.531 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . 1.393 ' OG ' ' CA ' ' A' ' 153' ' ' SER 0.33 1.4 m -101.64 147.29 26.6 Favored 'General case' 4 N--CA 1.195 -13.181 0 CA-C-N 113.28 -1.46 . . . . 3.1299999999999999 113.129 -179.731 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.134 ' CD ' ' CB ' ' A' ' 154' ' ' GLU . 0.6 OUTLIER -65.41 135.83 96.06 Favored Pre-proline 3 C--O 1.078 -7.97 0 N-CA-C 115.094 1.516 . . . . 3.27 115.094 179.214 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.577 ' HG3' ' HE1' ' A' ' 144' ' ' MET . 14.3 Cg_endo -62.91 -72.61 0.02 OUTLIER 'Trans proline' 3 C--O 0.877 -17.563 1 C-N-CA 127.053 5.169 . . . . 2.0299999999999998 114.279 -176.828 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 1.563 ' CZ ' ' CD ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -107.39 -45.76 4.01 Favored 'General case' 3 C--N 0.99 -15.051 2 O-C-N 106.061 -10.4 . . . . 4.04 109.808 177.587 . . . . . . . . 5 4 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 1.291 ' C ' ' CA ' ' A' ' 158' ' ' ASP . . . -169.58 33.85 0.02 OUTLIER 'General case' 4 C--O 0.763 -24.505 1 CA-C-O 134.423 6.82 . . . . 2.9199999999999999 109.332 -179.435 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 1.291 ' CA ' ' C ' ' A' ' 157' ' ' ALA . 16.9 t0 57.86 45.87 17.75 Favored 'General case' 4 C--O 0.786 -23.326 3 O-C-N 94.029 -17.92 . . . . 3.9900000000000002 105.535 -169.219 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.447 ' HB3' ' HD2' ' A' ' 156' ' ' ARG 0.414 18.9 t70 -104.93 -81.74 0.53 Allowed 'General case' 4 C--O 0.445 -41.259 3 O-C-N 108.9 -8.625 . . . . 4.3200000000000003 121.657 -171.744 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . 0.93 0.5 OUTLIER . . . . . 4 C--O 0.43 -42.074 4 O-C-N 94.248 -17.782 . . . . 4.7400000000000002 118.837 178.987 . . . . . . . . 4 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.5 tttt . . . . . 0 C--O 1.212 -0.894 0 N-CA-C 109.975 -0.38 . . . . 1.95 109.975 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -136.85 144.27 43.5 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 118.015 0.37 . . . . 0.33000000000000002 111.231 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 1.188 ' NE2' ' CG ' ' A' ' 37' ' ' GLN . 13.4 pt20 -148.48 135.33 19.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.28 -0.418 . . . . 1.3999999999999999 110.185 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.461 HG21 ' HB2' ' A' ' 59' ' ' ALA . 30.9 pt -116.71 135.77 55.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.037 0.446 . . . . 0.46000000000000002 110.997 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 1.57 ' CZ ' ' CD1' ' A' ' 39' ' ' PHE . 40.9 t80 -104.38 122.56 45.72 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.298 -0.63 . . . . 1.7 109.298 176.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.693 HD23 ' HB3' ' A' ' 66' ' ' ALA . 9.6 mp -91.11 146.51 23.78 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.106 -0.497 . . . . 0.88 111.286 -176.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 1.068 ' OE1' ' CG ' ' A' ' 41' ' ' GLU . 36.6 tt0 -73.71 125.45 28.11 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.719 -0.475 . . . . 1.49 109.719 178.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.38 -27.28 8.72 Favored Glycine 0 C--O 1.184 -3.025 0 C-N-CA 120.713 -0.756 . . . . 1.3300000000000001 111.957 -177.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.52 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 13.1 t -92.06 125.87 55.24 Favored Pre-proline 0 C--N 1.285 -2.234 0 O-C-N 121.236 -1.155 . . . . 1.1100000000000001 110.258 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.52 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 4.2 Cg_exo -80.9 0.44 10.02 Favored 'Trans proline' 0 N--CA 1.44 -1.632 0 C-N-CA 123.504 2.802 . . . . 1.3400000000000001 112.913 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -118.68 134.4 23.53 Favored Pre-proline 0 C--N 1.296 -1.722 0 O-C-N 121.875 -0.516 . . . . 1.1000000000000001 111.709 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 31.0 Cg_endo -90.58 146.1 4.01 Favored 'Trans proline' 0 N--CA 1.44 -1.642 0 C-N-CA 123.499 2.799 . . . . 0.81999999999999995 112.367 176.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.442 ' HB3' HG12 ' A' ' 38' ' ' ILE . 6.9 tt -96.23 113.36 24.95 Favored 'General case' 0 C--N 1.285 -2.216 0 O-C-N 121.507 -0.746 . . . . 1.03 109.021 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -111.81 140.61 46.31 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.675 0.274 . . . . 2.1800000000000002 111.584 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 1.634 ' CG ' ' CE2' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -146.41 145.35 30.22 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 116.077 -0.51 . . . . 1.97 109.886 177.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 m -63.32 -42.2 98.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.142 0.496 . . . . 1.1399999999999999 110.782 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 1.068 ' NE2' ' CG ' ' A' ' 51' ' ' GLN . 60.0 mt-30 -76.54 114.41 15.23 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.265 -0.425 . . . . 1.3600000000000001 110.552 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.603 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 14.5 t -62.72 -50.6 79.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.138 0.494 . . . . 0.48999999999999999 109.789 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.61 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -55.22 -31.76 61.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.983 -1.008 . . . . 1.2 112.568 -179.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 1.092 ' OD1' ' CB ' ' A' ' 54' ' ' ASP . 14.2 t70 -76.04 -48.84 19.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.852 0.358 . . . . 1.24 110.616 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 36' ' ' ALA . . . -67.79 -38.27 83.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.189 -0.459 . . . . 0.34000000000000002 111.433 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.587 ' CD1' ' HB3' ' A' ' 114' ' ' ALA . 22.6 pt -67.77 -31.53 52.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.709 0.29 . . . . 0.42999999999999999 110.339 178.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.15 -42.55 96.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.504 -0.316 . . . . 0.51000000000000001 110.521 174.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -60.4 -37.83 82.09 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.186 -0.461 . . . . 2.7599999999999998 110.951 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.461 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -66.11 -18.42 65.33 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.951 -0.568 . . . . 0.60999999999999999 111.933 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 1.394 ' NH1' ' NE ' ' A' ' 60' ' ' ARG . 2.0 mtm180 -98.71 7.14 46.43 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.148 0.425 . . . . 3.3199999999999998 112.148 -174.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -179.47 -67.07 0.07 OUTLIER Glycine 0 CA--C 1.474 -2.495 0 C-N-CA 120.043 -1.075 . . . . 0.90000000000000002 115.717 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.19 1.55 0.24 Allowed 'Trans proline' 1 C--O 0.964 -13.197 0 C-N-CA 123.385 2.723 . . . . 1.46 114.116 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . 0.324 0.0 OUTLIER -58.67 92.39 0.02 OUTLIER 'General case' 3 C--O 0.284 -49.751 3 O-C-N 111.462 -7.023 . . . . 2.6499999999999999 111.148 176.942 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 1.322 ' C ' ' CA ' ' A' ' 65' ' ' ILE 0.892 0.9 OUTLIER -78.62 -33.58 47.23 Favored 'General case' 4 C--O 0.697 -27.995 5 O-C-N 67.284 -34.635 . . . . 5.5499999999999998 146.622 -165.232 . . . . . . . . 6 4 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 1.322 ' CA ' ' C ' ' A' ' 64' ' ' GLN . 1.9 tt -130.22 -31.71 0.68 Allowed 'Isoleucine or valine' 3 C--N 0.847 -21.269 3 O-C-N 97.4 -15.812 . . . . 2.4900000000000002 110.006 -179.801 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.693 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -129.46 147.24 64.35 Favored Pre-proline 1 C--N 1.237 -4.302 0 O-C-N 119.381 -2.074 . . . . 1.2 109.724 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.726 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 62.4 Cg_endo -73.25 156.88 50.71 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.353 2.036 . . . . 0.97999999999999998 111.997 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.4 pt -77.16 123.13 33.19 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.382 0 CA-C-O 121.157 0.503 . . . . 0.77000000000000002 110.521 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.8 tt -86.04 -50.18 7.24 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.647 -0.871 . . . . 0.72999999999999998 108.647 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.9 p -159.46 140.18 4.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.294 -0.866 . . . . 0.40000000000000002 110.068 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.467 HD11 HG22 ' A' ' 56' ' ' ILE . 2.9 tt -113.2 131.86 63.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 116.074 -0.512 . . . . 0.34000000000000002 110.097 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 1.44 ' CG ' ' CE2' ' A' ' 72' ' ' TYR . 98.5 m-85 -112.22 133.57 54.27 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.309 -0.626 . . . . 1.3500000000000001 109.309 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.425 HG22 ' HB2' ' A' ' 94' ' ' ALA . 30.7 m -128.95 147.52 33.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 121.467 0.651 . . . . 0.29999999999999999 110.46 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -87.14 104.01 15.94 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.233 -1.025 . . . . 1.76 108.233 172.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 1.002 ' OD1' ' CB ' ' A' ' 75' ' ' ASP . 19.3 t70 -56.17 109.7 0.64 Allowed 'General case' 0 C--O 1.192 -1.932 0 O-C-N 125.099 1.5 . . . . 1.4099999999999999 110.617 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 1.435 ' C ' ' CA ' ' A' ' 77' ' ' GLY . 6.7 mtt -156.48 79.5 0.95 Allowed 'General case' 2 C--O 0.724 -26.597 1 CA-C-O 142.525 10.679 . . . . 3.8500000000000001 112.32 -176.557 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 1.435 ' CA ' ' C ' ' A' ' 76' ' ' MET . . . -167.92 78.91 0.11 Allowed Glycine 4 C--N 0.689 -35.403 5 O-C-N 83.498 -24.501 . . . . 3.02 145.659 -179.783 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 1.466 ' C ' ' CA ' ' A' ' 79' ' ' ALA 0.784 . . -101.08 124.05 46.2 Favored 'General case' 4 C--N 0.444 -38.802 4 CA-C-N 83.753 -16.223 . . . . 3.4199999999999999 127.545 -176.277 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 1.466 ' CA ' ' C ' ' A' ' 78' ' ' ALA 0.513 . . 79.87 -5.5 1.86 Allowed 'General case' 4 C--N 0.627 -30.836 4 O-C-N 74.446 -30.159 . . . . 3.2599999999999998 121.411 -178.061 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.859 ' N ' ' C ' ' A' ' 78' ' ' ALA . . . -161.77 -52.49 0.02 OUTLIER Glycine 4 N--CA 1.097 -23.932 3 C-N-CA 105.141 -8.171 . . . . 2.54 126.512 179.646 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 80' ' ' GLY 0.389 . . 52.65 50.64 17.72 Favored 'General case' 3 C--N 1.051 -12.4 0 CA-C-O 126.119 2.866 . . . . 2.02 113.088 -179.086 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.812 ' O ' ' HG2' ' A' ' 85' ' ' GLN 0.321 7.8 p -90.36 176.84 6.58 Favored 'General case' 4 CA--C 1.254 -10.419 1 CA-C-N 107.912 -4.222 . . . . 2.0299999999999998 107.317 -177.655 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 4.0 p90 -57.78 -26.69 62.26 Favored 'General case' 4 N--CA 1.207 -12.608 0 O-C-N 129.042 3.964 . . . . 3.79 108.385 175.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 1.195 ' OD1' ' CB ' ' A' ' 84' ' ' ASP 0.264 8.1 t70 -81.78 -31.19 31.98 Favored 'General case' 3 C--N 1.121 -9.347 1 CA-C-O 128.614 4.055 . . . . 3.1600000000000001 117.227 176.33 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 1.395 ' OE1' ' CG ' ' A' ' 85' ' ' GLN 0.376 8.9 mt-30 61.77 160.3 0.11 Allowed Pre-proline 4 C--O 1.009 -11.58 1 N-CA-C 124.946 5.165 . . . . 3.3799999999999999 124.946 176.554 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.775 ' HD2' ' HB3' ' A' ' 85' ' ' GLN 0.314 10.3 Cg_endo -79.24 -17.99 11.37 Favored 'Trans proline' 4 N--CA 1.323 -8.551 1 C-N-CA 127.532 5.488 . . . . 1.99 120.527 175.244 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.953 ' O ' ' CE ' ' A' ' 76' ' ' MET . . . 131.27 -162.27 23.63 Favored Glycine 4 C--O 0.763 -29.309 0 CA-C-O 127.31 3.728 . . . . 1.6799999999999999 115.315 -178.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.514 ' HA ' ' HE1' ' A' ' 76' ' ' MET 0.696 4.4 m-20 -75.22 142.79 43.36 Favored 'General case' 4 C--O 0.632 -31.432 5 O-C-N 98.011 -14.817 . . . . 4.79 134.136 177.642 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . -143.55 -152.84 5.73 Favored Glycine 3 N--CA 1.038 -27.887 3 N-CA-C 138.022 9.969 . . . . 1.25 138.022 -176.037 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 75' ' ' ASP . 16.7 m-20 -95.66 149.79 21.08 Favored 'General case' 0 C--O 1.158 -3.75 0 O-C-N 121.724 -0.868 . . . . 2.6099999999999999 111.467 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.662 ' CE2' ' HZ3' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -101.95 129.24 48.18 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 119.964 1.256 . . . . 3.9399999999999999 110.683 179.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.852 HG21 ' HB2' ' A' ' 118' ' ' SER . 13.2 pt -143.19 162.01 17.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.013 -0.54 . . . . 0.53000000000000003 111.539 -175.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.69 108.46 18.04 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.546 -0.539 . . . . 0.34999999999999998 109.546 172.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -64.67 -35.3 80.57 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.43 -0.35 . . . . 0.34000000000000002 111.686 -174.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 1.404 ' OD1' ' CB ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -64.0 -23.93 67.52 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-O 121.671 0.748 . . . . 1.4399999999999999 110.548 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -111.93 33.06 5.03 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.108 -0.951 . . . . 1.0800000000000001 110.621 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.94 -179.74 5.67 Favored 'General case' 0 C--N 1.311 -1.092 0 O-C-N 121.745 -0.597 . . . . 0.34999999999999998 111.022 -172.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 1.402 ' CZ ' ' CD2' ' A' ' 98' ' ' PHE . 97.4 m-85 -93.97 136.98 33.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.423 0.63 . . . . 1.24 110.355 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 1.517 ' CZ ' ' CD1' ' A' ' 99' ' ' TYR . 2.8 m-85 -120.48 135.74 54.97 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.248 -0.887 . . . . 1.3799999999999999 109.785 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.52 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.5 p -114.69 124.3 71.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.558 0.694 . . . . 0.35999999999999999 109.893 172.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.41 HG23 HD11 ' A' ' 135' ' ' LEU . 49.0 t -102.19 111.47 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 114.786 -1.097 . . . . 0.56000000000000005 108.567 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.58 125.96 8.28 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.748 -0.739 . . . . 0.67000000000000004 112.743 -175.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 1.073 ' CB ' ' OG ' ' A' ' 103' ' ' SER . 3.3 m -91.67 -29.83 16.65 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 120.896 0.379 . . . . 1.4299999999999999 110.646 177.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.93 -43.2 18.43 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.241 -0.436 . . . . 0.96999999999999997 111.259 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 1.5 ' CD ' ' CZ ' ' A' ' 105' ' ' ARG . 59.6 mtp180 -128.14 107.29 9.68 Favored 'General case' 1 C--O 0.621 -32.021 1 CA-C-O 129.716 4.579 . . . . 2.8300000000000001 111.079 178.52 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.877 ' CZ ' ' O ' ' A' ' 113' ' ' GLU . 3.1 tpm_? -171.6 -137.82 0.02 OUTLIER 'General case' 2 C--O 0.637 -31.168 4 O-C-N 84.441 -23.912 . . . . 5.0199999999999996 114.742 177.331 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.826 ' O ' ' N ' ' A' ' 109' ' ' MET . . . -109.14 -22.21 6.97 Favored Glycine 4 C--O 0.812 -26.256 3 O-C-N 86.792 -22.442 . . . . 1.7 119.796 -179.371 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 17.4 -65.41 0.0 OUTLIER Glycine 4 C--N 0.906 -23.342 2 O-C-N 108.068 -8.901 . . . . 2.1099999999999999 119.78 179.839 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 1.525 ' CG ' ' CA ' ' A' ' 109' ' ' MET . 40.0 mtm -97.74 2.02 49.11 Favored 'General case' 4 C--N 1.164 -7.492 0 O-C-N 117.067 -3.608 . . . . 5.0999999999999996 114.983 177.167 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -130.86 -121.95 2.35 Favored Glycine 4 C--N 1.104 -12.34 0 CA-C-N 110.675 -2.966 . . . . 1.54 111.154 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.461 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -104.69 99.97 21.03 Favored Pre-proline 0 N--CA 1.392 -3.368 0 CA-C-N 118.797 1.299 . . . . 1.4399999999999999 113.101 177.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 27.3 Cg_endo -63.96 139.75 69.28 Favored 'Trans proline' 0 C--N 1.274 -3.373 0 C-N-CA 123.247 2.631 . . . . 1.0600000000000001 114.025 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.877 ' O ' ' CZ ' ' A' ' 106' ' ' ARG . 42.7 mt-10 -117.12 136.32 53.1 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.711 -0.677 . . . . 2.1600000000000001 110.341 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.587 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . . . -104.84 131.2 52.62 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 122.347 0.259 . . . . 0.40999999999999998 110.698 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.52 ' HB ' HG13 ' A' ' 100' ' ' VAL . 87.2 t -100.76 105.7 39.31 Favored Pre-proline 0 C--N 1.316 -0.89 0 C-N-CA 120.21 -0.596 . . . . 0.93000000000000005 110.077 174.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 5.9 Cg_exo -87.87 124.04 1.8 Allowed 'Trans proline' 0 C--O 1.212 -0.775 0 C-N-CA 123.819 3.012 . . . . 0.46999999999999997 112.195 177.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -128.12 150.09 50.13 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 122.431 0.292 . . . . 2.1899999999999999 110.57 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.852 ' HB2' HG21 ' A' ' 92' ' ' ILE . 32.2 t -80.22 -30.26 38.6 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.205 0.526 . . . . 0.81000000000000005 110.32 175.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 16.3 m -98.15 122.29 41.11 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 116.051 -0.522 . . . . 0.65000000000000002 110.618 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -61.61 -45.2 95.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.071 0.462 . . . . 1.48 111.423 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 1.014 ' OD2' ' CB ' ' A' ' 121' ' ' ASP . 54.2 p30 -63.49 -29.6 70.85 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.717 -0.674 . . . . 1.3100000000000001 110.981 -173.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.954 ' OE1' ' CG ' ' A' ' 122' ' ' GLU . 32.2 mm-40 -67.78 -41.13 83.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.067 -0.515 . . . . 1.25 110.596 174.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.07 -36.55 80.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.198 0.523 . . . . 0.28999999999999998 110.146 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.94 -38.78 86.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.678 -0.692 . . . . 0.32000000000000001 111.041 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.32 -34.84 77.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.315 -0.402 . . . . 0.45000000000000001 110.649 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 1.52 ' CZ ' ' CD1' ' A' ' 126' ' ' PHE . 44.1 t80 -62.72 -39.7 94.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.144 -0.48 . . . . 1.5 109.841 175.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.623 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 75.3 t -70.36 -33.39 53.88 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 CA-C-N 115.922 -0.581 . . . . 0.59999999999999998 110.686 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 1.453 ' CD2' ' CB ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -57.69 -40.77 80.24 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.268 0.556 . . . . 1.74 110.491 177.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.12 -46.8 14.4 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.901 -0.59 . . . . 0.97999999999999998 110.761 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 1.151 ' OE2' ' CG ' ' A' ' 130' ' ' GLU . 8.8 pt-20 -154.23 -73.79 0.12 Allowed 'General case' 1 C--O 1.105 -6.509 0 CA-C-O 123.096 1.426 . . . . 1.8999999999999999 111.515 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.834 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 24.02 -152.68 0.0 OUTLIER Glycine 2 C--O 1.033 -12.438 0 O-C-N 117.498 -3.251 . . . . 1.02 114.54 176.127 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.455 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -159.33 -83.79 0.05 OUTLIER Glycine 1 C--N 1.233 -5.178 0 CA-C-N 123.81 3.805 . . . . 0.51000000000000001 111.525 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 1.304 ' NE2' ' CG ' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -129.29 142.81 50.73 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.721 0.296 . . . . 1.6599999999999999 110.763 177.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.6 116.01 45.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.063 -0.517 . . . . 0.42999999999999999 109.844 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.849 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -139.71 161.3 37.87 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.762 -0.653 . . . . 0.51000000000000001 109.986 -178.357 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.8 164.38 17.6 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.921 -0.487 . . . . 0.53000000000000003 109.719 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.866 HD13 ' HA ' ' A' ' 95' ' ' ASP . 1.8 tt -62.5 -33.25 74.5 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.477 0.656 . . . . 1.26 110.036 178.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.84 -13.8 62.17 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.385 -0.825 . . . . 0.90000000000000002 111.36 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 1.238 ' OD2' ' CB ' ' A' ' 139' ' ' ASP . 5.1 t70 -117.86 17.65 14.18 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.112 0.482 . . . . 1.73 110.994 -175.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.849 HD13 HD13 ' A' ' 135' ' ' LEU . 32.4 mm -72.05 121.87 23.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.334 0.588 . . . . 0.75 109.965 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.1 t -113.86 147.77 37.85 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.746 -0.661 . . . . 0.80000000000000004 109.842 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 1.048 ' OD2' ' CB ' ' A' ' 142' ' ' ASP . 6.4 p-10 -69.41 -29.36 67.07 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.372 -0.376 . . . . 1.55 111.225 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.92 -29.06 69.96 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.101 -0.5 . . . . 0.87 111.648 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 1.092 ' SD ' ' CE ' ' A' ' 144' ' ' MET . 21.5 mmt -82.42 -32.9 28.81 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-O 120.766 0.317 . . . . 1.7 111.477 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 5.6 t -85.56 -22.5 7.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 116.536 -0.302 . . . . 1.1699999999999999 110.814 -174.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.2 pp -155.43 139.7 16.64 Favored 'General case' 0 C--O 1.193 -1.892 0 CA-C-O 121.451 0.643 . . . . 1.54 110.951 -176.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.6 p -107.37 126.59 29.67 Favored Pre-proline 0 C--N 1.269 -2.928 0 CA-C-O 121.834 0.826 . . . . 1.6699999999999999 111.086 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -66.63 -68.49 0.03 OUTLIER 'Trans proline' 3 C--O 1.095 -6.661 0 CA-C-O 124.247 1.686 . . . . 2.1499999999999999 112.34 176.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 149' ' ' VAL . 4.0 t -133.7 2.43 1.36 Allowed 'Isoleucine or valine' 4 C--O 0.957 -14.293 0 O-C-N 118.548 -2.595 . . . . 3.3900000000000001 109.349 176.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 1.277 ' OE2' ' CG ' ' A' ' 150' ' ' GLU . 36.9 mt-10 66.42 -44.28 0.42 Allowed 'General case' 3 C--O 0.745 -25.482 1 CA-C-O 131.389 5.376 . . . . 3.2799999999999998 110.427 -173.197 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.4 t 10.28 -0.8 0.0 OUTLIER 'General case' 4 C--N 0.914 -18.363 3 O-C-N 93.59 -18.194 . . . . 3.9300000000000002 112.54 177.95 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.829 ' N ' ' O ' ' A' ' 150' ' ' GLU . . . 77.72 50.79 6.28 Favored Glycine 4 CA--C 1.253 -16.323 1 N-CA-C 137.27 9.668 . . . . 3.7200000000000002 137.27 -178.531 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 1.393 ' OG ' ' CA ' ' A' ' 153' ' ' SER 0.33 1.4 m -101.64 147.29 26.6 Favored 'General case' 4 N--CA 1.195 -13.181 0 CA-C-N 113.28 -1.46 . . . . 3.1299999999999999 113.129 -179.731 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.134 ' CD ' ' CB ' ' A' ' 154' ' ' GLU . 0.6 OUTLIER -65.41 135.83 96.06 Favored Pre-proline 3 C--O 1.078 -7.97 0 N-CA-C 115.094 1.516 . . . . 3.27 115.094 179.214 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.577 ' HG3' ' HE1' ' A' ' 144' ' ' MET . 14.3 Cg_endo -62.91 -72.61 0.02 OUTLIER 'Trans proline' 3 C--O 0.877 -17.563 1 C-N-CA 127.053 5.169 . . . . 2.0299999999999998 114.279 -176.828 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 1.563 ' CZ ' ' CD ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -107.39 -45.76 4.01 Favored 'General case' 3 C--N 0.99 -15.051 2 O-C-N 106.061 -10.4 . . . . 4.04 109.808 177.587 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 1.291 ' C ' ' CA ' ' A' ' 158' ' ' ASP . . . -169.58 33.85 0.02 OUTLIER 'General case' 4 C--O 0.763 -24.505 1 CA-C-O 134.423 6.82 . . . . 2.9199999999999999 109.332 -179.435 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 1.291 ' CA ' ' C ' ' A' ' 157' ' ' ALA . 16.9 t0 57.86 45.87 17.75 Favored 'General case' 4 C--O 0.786 -23.326 3 O-C-N 94.029 -17.92 . . . . 3.9900000000000002 105.535 -169.219 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.447 ' HB3' ' HD2' ' A' ' 156' ' ' ARG 0.414 18.9 t70 -104.93 -81.74 0.53 Allowed 'General case' 4 C--O 0.445 -41.259 3 O-C-N 108.9 -8.625 . . . . 4.3200000000000003 121.657 -171.744 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . 0.93 0.5 OUTLIER . . . . . 4 C--O 0.43 -42.074 4 O-C-N 94.248 -17.782 . . . . 4.7400000000000002 118.837 178.987 . . . . . . . . 4 2 . 1 stop_ save_